Investors

Are you interested in investing in Canify AG? Find out more here:

Invest here

Investors

Good reasons for an investment

Billions are already being generated with medical cannabis. Nevertheless, the European market is still in its early stages. Industry revenue is expected to grow from USD 2.6 billion in 2024 to USD 12.6 billion by 2033 (source: imarcgroup.com).

The Canify management team brings together expertise from the fields of pharmaceuticals, cannabis, finance, and capital markets. Together, the team has more than 100 years of experience in the healthcare sector.

As a GMP-certified pharmaceutical company, we deliver the highest quality, have built a scalable platform, and develop innovative products.

Since the second half of 2024, Canify AG has been profitable. We are now aiming for strong continued growth and scaling, laying the groundwork for an IPO at a significantly higher valuation.

Canify General Assembly 2025

Icon

Canify HV25 Einla­dung

1 file(s) 166.72 KB
Download
Icon

Canify HV25 Bericht Aufsichtsrat

1 file(s) 33.20 KB
Download
Icon

Canify AG Anmeldung und Vollmacht HV2025

1 file(s) 141.85 KB
Download

Analyst report rates the development of Canify AG as extremely positive.

According to the latest report by international industry experts Zuanic & Associates, Canify AG is projected to increase its revenue sixfold by 2027 compared to 2024. By the end of 2025, revenues are expected to reach 21 million euros. Key factors driving this growth include unique selling points such as diversified supply chains, an in-house EU-GMP processing facility, and a steadily growing portfolio of innovative pharmaceutical products
To the report (original)
To the report (German)
To the press release (German)

Watch industry analyst Pablo Zuanic in conversation with the executive board of Canify AG:

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

We’d be happy to keep you informed.

Feel free to sign up to be added to our investor mailing list.

    Fields marked with an asterisk (*) are required.

    By submitting your data, you allow us to collect, store, and use it, and you grant us revocable permission to send you information about our services at irregular intervals. Privacy Policy

    captcha
    Enter the characters shown in the image:
    Reload

    This CAPTCHA helps ensure that you are human. Please enter the requested characters.

    Or write to us: ir@canify.com

    Further information

    Financial documents
    Scroll to Top